Theradaptive, a Maryland-based, privately held, clinical-stage biologics company, today announced the initiation of patient dosing in Maryland for the ongoing OASIS Phase I/II clinical trial assessing ...
As U.S. markets navigate a period of uncertainty with the Federal Reserve maintaining interest rates and investors closely watching major tech earnings, attention turns to identifying promising growth ...